Related Experiment Video
Updated: Aug 9, 2026

16:49
Multifocal Electroretinograms
Published on: December 4, 2011
Recurrent Miller Fisher syndrome
S Madhavan1, Geetha, P V Bhargavan
1Department of Medicine, Medical College, Calicut.
The Journal of the Association of Physicians of India
|January 14, 2005
Summary
Recurrent Miller Fisher syndrome (MFS), a Guillain-Barré variant, is exceptionally rare. This case report details two MFS episodes in one patient over two years, highlighting atypical recurrence for this neurological disorder.
Area of Science:
- Neurology
- Neuroimmunology
Background:
- Miller Fisher syndrome (MFS) is a rare autoimmune disorder and a variant of Guillain-Barré syndrome.
- MFS is typically characterized by ophthalmoplegia, ataxia, and areflexia, with recurrences being exceedingly uncommon.
Observation:
- This report presents a unique case of a patient experiencing two distinct episodes of MFS within a two-year timeframe.
- The initial presentation involved partial ophthalmoplegia and ataxia, while the second episode manifested as a full triad of ataxia, areflexia, and ophthalmoplegia.
Findings:
- Cerebrospinal fluid (CSF) analysis remained consistent with MFS during both episodes.
- Nerve conduction velocity studies and brain MRI were within normal limits, underscoring the clinical diagnosis.
- The patient initially received symptomatic treatment, followed by steroid therapy during the second MFS episode, with positive response.
Implications:
- This case underscores the possibility of recurrent MFS, challenging the notion of its exceptional rarity.
- It highlights the importance of considering recurrent MFS in patients presenting with similar neurological symptoms, even after a prior MFS diagnosis.
- The varied response to treatment suggests further research into optimal therapeutic strategies for recurrent MFS is warranted.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.

